Annual EBIT
$107.28 M
-$5.35 M-4.75%
December 31, 2023
Summary
- As of February 12, 2025, CORT annual earnings before interest & taxes is $107.28 million, with the most recent change of -$5.35 million (-4.75%) on December 31, 2023.
- During the last 3 years, CORT annual EBIT has fallen by -$20.92 million (-16.32%).
- CORT annual EBIT is now -16.32% below its all-time high of $128.20 million, reached on December 31, 2020.
Performance
CORT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$46.60 M
+$11.01 M+30.92%
September 30, 2024
Summary
- As of February 12, 2025, CORT quarterly earnings before interest & taxes is $46.60 million, with the most recent change of +$11.01 million (+30.92%) on September 30, 2024.
- Over the past year, CORT quarterly EBIT has increased by +$17.10 million (+57.96%).
- CORT quarterly EBIT is now at all-time high.
Performance
CORT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$143.36 M
+$15.42 M+12.05%
September 30, 2024
Summary
- As of February 12, 2025, CORT TTM earnings before interest & taxes is $143.36 million, with the most recent change of +$15.42 million (+12.05%) on September 30, 2024.
- Over the past year, CORT TTM EBIT has increased by +$21.43 million (+17.58%).
- CORT TTM EBIT is now at all-time high.
Performance
CORT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CORT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.8% | +58.0% | +17.6% |
| 3 y3 years | -16.3% | +107.1% | +27.3% |
| 5 y5 years | +19.9% | +107.1% | +27.3% |
CORT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.8% | at low | at high | +213.7% | at high | +46.1% |
| 5 y | 5-year | -16.3% | at low | at high | +213.7% | at high | +46.1% |
| alltime | all time | -16.3% | +358.5% | at high | +462.4% | at high | +430.2% |
Corcept Therapeutics Incorporated EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $46.60 M(+30.9%) | $143.36 M(+12.1%) |
| Jun 2024 | - | $35.59 M(+20.7%) | $127.94 M(+4.9%) |
| Mar 2024 | - | $29.50 M(-6.8%) | $121.93 M(+13.7%) |
| Dec 2023 | $107.28 M(-4.8%) | $31.67 M(+1.6%) | $107.28 M(+9.3%) |
| Sep 2023 | - | $31.18 M(+5.4%) | $98.11 M(-0.8%) |
| Jun 2023 | - | $29.58 M(+99.2%) | $98.87 M(-1.8%) |
| Mar 2023 | - | $14.85 M(-34.0%) | $100.72 M(-10.6%) |
| Dec 2022 | $112.63 M(-9.5%) | $22.50 M(-29.5%) | $112.63 M(-11.2%) |
| Sep 2022 | - | $31.93 M(+1.6%) | $126.80 M(-3.3%) |
| Jun 2022 | - | $31.43 M(+17.4%) | $131.10 M(-0.4%) |
| Mar 2022 | - | $26.77 M(-27.0%) | $131.61 M(+5.7%) |
| Dec 2021 | $124.48 M(-2.9%) | $36.66 M(+1.2%) | $124.48 M(+5.2%) |
| Sep 2021 | - | $36.23 M(+13.4%) | $118.32 M(+10.8%) |
| Jun 2021 | - | $31.94 M(+62.7%) | $106.81 M(-3.0%) |
| Mar 2021 | - | $19.64 M(-35.6%) | $110.13 M(-14.1%) |
| Dec 2020 | $128.20 M(+14.9%) | $30.51 M(+23.4%) | $128.20 M(-3.4%) |
| Sep 2020 | - | $24.72 M(-29.9%) | $132.71 M(-5.9%) |
| Jun 2020 | - | $35.26 M(-6.5%) | $140.99 M(+8.2%) |
| Mar 2020 | - | $37.71 M(+7.7%) | $130.36 M(+16.8%) |
| Dec 2019 | $111.61 M(+24.7%) | $35.02 M(+6.1%) | $111.61 M(+10.0%) |
| Sep 2019 | - | $33.00 M(+34.0%) | $101.49 M(+11.0%) |
| Jun 2019 | - | $24.63 M(+29.9%) | $91.46 M(+4.6%) |
| Mar 2019 | - | $18.96 M(-23.9%) | $87.46 M(-2.3%) |
| Dec 2018 | $89.50 M(+69.3%) | $24.90 M(+8.4%) | $89.50 M(+3.7%) |
| Sep 2018 | - | $22.97 M(+11.3%) | $86.30 M(+12.1%) |
| Jun 2018 | - | $20.63 M(-1.7%) | $76.95 M(+11.3%) |
| Mar 2018 | - | $21.00 M(-3.2%) | $69.11 M(+30.8%) |
| Dec 2017 | $52.85 M(+419.3%) | $21.70 M(+59.3%) | $52.85 M(+46.1%) |
| Sep 2017 | - | $13.62 M(+6.5%) | $36.16 M(+41.2%) |
| Jun 2017 | - | $12.79 M(+169.9%) | $25.61 M(+78.8%) |
| Mar 2017 | - | $4.74 M(-5.3%) | $14.33 M(+40.8%) |
| Dec 2016 | $10.18 M(-395.6%) | $5.01 M(+63.0%) | $10.18 M(+49.2%) |
| Sep 2016 | - | $3.07 M(+103.7%) | $6.82 M(+77.1%) |
| Jun 2016 | - | $1.51 M(+154.7%) | $3.85 M(+226.8%) |
| Mar 2016 | - | $592.00 K(-64.1%) | $1.18 M(-134.2%) |
| Dec 2015 | -$3.44 M(-87.5%) | $1.65 M(+1518.6%) | -$3.44 M(-57.9%) |
| Sep 2015 | - | $102.00 K(-108.7%) | -$8.17 M(-38.9%) |
| Jun 2015 | - | -$1.17 M(-71.1%) | -$13.38 M(-28.8%) |
| Mar 2015 | - | -$4.03 M(+31.0%) | -$18.79 M(-32.0%) |
| Dec 2014 | -$27.62 M(-33.4%) | -$3.08 M(-39.7%) | -$27.62 M(-20.1%) |
| Sep 2014 | - | -$5.10 M(-22.5%) | -$34.57 M(-11.8%) |
| Jun 2014 | - | -$6.58 M(-48.8%) | -$39.21 M(-9.7%) |
| Mar 2014 | - | -$12.86 M(+28.2%) | -$43.41 M(+4.6%) |
| Dec 2013 | -$41.50 M | -$10.03 M(+3.0%) | -$41.50 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$9.74 M(-9.7%) | -$41.45 M(+5.3%) |
| Jun 2013 | - | -$10.78 M(-1.5%) | -$39.38 M(+8.8%) |
| Mar 2013 | - | -$10.94 M(+9.6%) | -$36.19 M(-0.2%) |
| Dec 2012 | -$36.27 M(+12.2%) | -$9.98 M(+30.1%) | -$36.27 M(+0.2%) |
| Sep 2012 | - | -$7.67 M(+1.0%) | -$36.22 M(+3.5%) |
| Jun 2012 | - | -$7.59 M(-31.2%) | -$34.98 M(-3.5%) |
| Mar 2012 | - | -$11.03 M(+11.1%) | -$36.26 M(+12.2%) |
| Dec 2011 | -$32.33 M(+24.6%) | -$9.93 M(+54.2%) | -$32.33 M(+12.5%) |
| Sep 2011 | - | -$6.44 M(-27.4%) | -$28.73 M(-2.3%) |
| Jun 2011 | - | -$8.87 M(+25.0%) | -$29.40 M(+9.0%) |
| Mar 2011 | - | -$7.10 M(+12.2%) | -$26.98 M(+4.0%) |
| Dec 2010 | -$25.94 M(+28.1%) | -$6.33 M(-10.9%) | -$25.94 M(+4.7%) |
| Sep 2010 | - | -$7.11 M(+10.2%) | -$24.78 M(+10.9%) |
| Jun 2010 | - | -$6.45 M(+6.3%) | -$22.34 M(+7.5%) |
| Mar 2010 | - | -$6.06 M(+17.5%) | -$20.78 M(+2.6%) |
| Dec 2009 | -$20.25 M(+2.8%) | -$5.16 M(+10.6%) | -$20.25 M(-4.0%) |
| Sep 2009 | - | -$4.67 M(-4.3%) | -$21.10 M(-1.1%) |
| Jun 2009 | - | -$4.88 M(-11.8%) | -$21.34 M(+0.9%) |
| Mar 2009 | - | -$5.53 M(-8.0%) | -$21.14 M(+7.4%) |
| Dec 2008 | -$19.69 M(+60.8%) | -$6.02 M(+22.7%) | -$19.69 M(+8.8%) |
| Sep 2008 | - | -$4.90 M(+4.6%) | -$18.09 M(+7.6%) |
| Jun 2008 | - | -$4.69 M(+14.8%) | -$16.81 M(+22.7%) |
| Mar 2008 | - | -$4.08 M(-7.6%) | -$13.70 M(+11.9%) |
| Dec 2007 | -$12.24 M(-52.1%) | -$4.42 M(+22.1%) | -$12.24 M(+3.6%) |
| Sep 2007 | - | -$3.62 M(+129.1%) | -$11.82 M(-19.9%) |
| Jun 2007 | - | -$1.58 M(-39.9%) | -$14.75 M(-30.5%) |
| Mar 2007 | - | -$2.63 M(-34.2%) | -$21.23 M(-17.0%) |
| Dec 2006 | -$25.58 M(+20.9%) | -$3.99 M(-39.1%) | -$25.58 M(-5.6%) |
| Sep 2006 | - | -$6.55 M(-18.8%) | -$27.10 M(+4.1%) |
| Jun 2006 | - | -$8.06 M(+15.5%) | -$26.03 M(+16.5%) |
| Mar 2006 | - | -$6.98 M(+26.8%) | -$22.35 M(+5.6%) |
| Dec 2005 | -$21.16 M(+31.9%) | -$5.50 M(+0.4%) | -$21.16 M(-0.1%) |
| Sep 2005 | - | -$5.48 M(+25.0%) | -$21.18 M(+6.1%) |
| Jun 2005 | - | -$4.39 M(-24.2%) | -$19.95 M(+3.6%) |
| Mar 2005 | - | -$5.79 M(+4.8%) | -$19.26 M(+20.0%) |
| Dec 2004 | -$16.05 M(+60.9%) | -$5.52 M(+29.7%) | -$16.05 M(+27.9%) |
| Sep 2004 | - | -$4.26 M(+15.3%) | -$12.54 M(+20.1%) |
| Jun 2004 | - | -$3.69 M(+43.8%) | -$10.44 M(+8.0%) |
| Mar 2004 | - | -$2.57 M(+27.3%) | -$9.67 M(-3.0%) |
| Dec 2003 | -$9.97 M(-47.0%) | -$2.02 M(-6.7%) | -$9.97 M(+25.4%) |
| Sep 2003 | - | -$2.16 M(-26.0%) | -$7.95 M(+37.3%) |
| Jun 2003 | - | -$2.92 M(+2.0%) | -$5.79 M(+102.0%) |
| Mar 2003 | - | -$2.87 M | -$2.87 M |
| Dec 2002 | -$18.80 M(+134.8%) | - | - |
| Dec 2001 | -$8.01 M | - | - |
FAQ
- What is Corcept Therapeutics Incorporated annual earnings before interest & taxes?
- What is the all time high annual EBIT for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual EBIT year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly EBIT year-on-year change?
- What is Corcept Therapeutics Incorporated TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM EBIT year-on-year change?
What is Corcept Therapeutics Incorporated annual earnings before interest & taxes?
The current annual EBIT of CORT is $107.28 M
What is the all time high annual EBIT for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual earnings before interest & taxes is $128.20 M
What is Corcept Therapeutics Incorporated annual EBIT year-on-year change?
Over the past year, CORT annual earnings before interest & taxes has changed by -$5.35 M (-4.75%)
What is Corcept Therapeutics Incorporated quarterly earnings before interest & taxes?
The current quarterly EBIT of CORT is $46.60 M
What is the all time high quarterly EBIT for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly earnings before interest & taxes is $46.60 M
What is Corcept Therapeutics Incorporated quarterly EBIT year-on-year change?
Over the past year, CORT quarterly earnings before interest & taxes has changed by +$17.10 M (+57.96%)
What is Corcept Therapeutics Incorporated TTM earnings before interest & taxes?
The current TTM EBIT of CORT is $143.36 M
What is the all time high TTM EBIT for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM earnings before interest & taxes is $143.36 M
What is Corcept Therapeutics Incorporated TTM EBIT year-on-year change?
Over the past year, CORT TTM earnings before interest & taxes has changed by +$21.43 M (+17.58%)